Survey Report on Parents and Patients Related to the Use of Cannabidiol Symptomatic Epilepsy Secondary to Tuberous Sclerosis Complex (TSC) in Mexico

Journal Title: Journal of Advances in Medicine and Medical Research - Year 2017, Vol 23, Issue 12

Abstract

A descriptive observational study using a structured survey was circulated through Facebook networks that comprised of parents of children and patients with tuberous sclerosis complex and epilepsy on conventional or medicinal cannabis/cannabidiol (CBD) treatment. Of 105 surveys, 58 were obtained by self-selection and 10 from patients treated with CBD. Forty-seven children and 11 adults, 52% male, 48% female, were included. Epileptic syndromes were present in 70.6% of the cases of which Lennox-Gastaut Syndrome (LGS) was in 20, West syndrome (WS) in 20, and epilepsy with myoclonic-astatic crises (MAE) in 6. Refractory epilepsy (RE) was present in 22 (38%) cases. Ten patients (17.2%) underwent CBD treatment; seizures decreased for 7 patients, with significant decreases in 6 and minor decreases in 1. No effect was seen in 3 patients and there were no seizure-free cases or cases where the seizure worsened. Improvement in quality of life parameters were observed. Mild adverse events were observed in 4 cases (40%). Monthly treatment costs ranged from $300 pesos with CBD to $35,000 pesos with everolimus. Average monthly costs with CBD were $4,039 ± 2,530 pesos. Patient and parent reports suggest medicinal cannabis is a therapeutic option offering improvement in seizures and quality of life at a moderate cost.

Authors and Affiliations

Carlos G. Aguirre-Velázquez, Mario Peral-Ríos, Evelyn López-Guevara, Kenny Lemus-Roldán

Keywords

Related Articles

A Comparative Study to Evaluate the Interplay of Lipoprotein (a) With Traditional Lipid Parameters in Overt and Subclinical Hypothyroidism

Aims: In conjunction with triglyceride (TG) and HDLc, changes in the Lp (a) level in hypothyroidism have shown variable results. In the present study we made an effort to evaluate the role of Lp(a) as cardiovascular risk...

FGF21 maybe have a Protective Role against Obesity in Cases of High-fat Diets, in Adult Mice, Malnourished during Their Embryonic Life

Aims: To investigate if there is a possible protective role of FGF21 in malnourished adult mice which have been exposed to stress during their intrauterine life. Place and Duration of Study: University of Patras, Departm...

Possible Benefits of the Whole Body Vibration in the Treatment of Complications in Stroke Patients

Aims: A stroke is a neurological disorder and muscle weakness is the most prominent impairment. Whole-body vibration (WBV) is a possible modality of exercise that is useful for improving physical capacity, bone mass, bal...

Obesity in Adolescents: Assessment by DXA Scan and Skinfold Thickness Equations

Aim: This study aimed to compare obesity, estimated percentage of fat in adolescents in Brazil, using Dual-Energy X-Ray Absorptiometry (DXA) with skinfold data that were entered into mathematical models. Study Design:...

A Pilot Study of Family Stigma in Alzheimer’s Disease: Slovenian Perspective

Since the population of patients with AD is growing and the disease is affecting more and more people, the main goal of this paper was to investigate the process of stigmatisation of family caregivers, when a family memb...

Download PDF file
  • EP ID EP312431
  • DOI 10.9734/JAMMR/2017/36585
  • Views 80
  • Downloads 0

How To Cite

Carlos G. Aguirre-Velázquez, Mario Peral-Ríos, Evelyn López-Guevara, Kenny Lemus-Roldán (2017). Survey Report on Parents and Patients Related to the Use of Cannabidiol Symptomatic Epilepsy Secondary to Tuberous Sclerosis Complex (TSC) in Mexico. Journal of Advances in Medicine and Medical Research, 23(12), 1-8. https://europub.co.uk/articles/-A-312431